The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Abemaciclib with or without fulvestrant for the treatment of hormone receptor-positive and HER2-negative metastatic breast cancer with disease progression following prior treatment with palbociclib.

Keerthi  Tamragouri

No Relationships to Disclose

Melody A.  Cobleigh

Consulting or Advisory Role - Genomic Health; Immunomedics; Puma Biotechnology; Roche/Genentech

Patents, Royalties, Other Intellectual Property - Genomic Health

Travel, Accommodations, Expenses - genentech; Immunomedics; Puma Biotechnology

Ruta D.  Rao

Consulting or Advisory Role - AstraZeneca; Novartis

Speakers' Bureau - Genentech/Roche; Genomic Health; Puma Biotechnology